• Home  HOME
  • About  ABOUT US
  • About  PRODUCTS
  • Research  RESEARCH
  • Investors  INVESTOR RELATIONS
  • Contact  CONTACT
  • AFFILIATED WEBSITES
  • Contact
  •  ABOUT US
  • History
  •  PRODUCTS
  • USA
  • Canada
  • Israel
  • International
  •  INVESTOR RELATIONS
  • Investor Relations
  • Financials
  • Annual Reports
  • Fundamentals
  • Earnings & Proxy Reports
  • News Releases
  • Investor FAQ
  • E-mail Alerts
  • Contact Information
  • Safe Harbor
  • AFFILIATED WEBSITES
  • Taro Pharmaceutical Industries Ltd. Taro U.S.A
  • Taro Canada Taro Canada
  • Taro Israel Taro Israel
  • Taro International Taro International
  • Sun Pharmaceutical Ind. Ltd
  • Sun Pharmaceutical USA
  • Chattem Chemicals Inc.
Skip to main content

Taro Pharmaceutical Industries

  • WORLDWIDE SITES
      • USA
      • Canada
      • Israel
      • International
Text Size A A A

Taro-Clindamycin, Solution topique

Print Home » Taro-Clindamycin, Solution topique
Submitted by admin on Thu, 02/06/2014 - 17:04
Upload Pdf: 
PDF icon Taro_Clindamycin_1_PM FR.pdf
Image: 
Principes actifs: 
Phosphate de clindamycine
CUP: 
063691052338/063691052307
DIN: 
02266938/02266938
Format: 
30 ml/60 mL
Qte/caisses: 
24/24
Listes de Medicaments: 
BC, SK, MB, QC, NB, NS, PEI, YK, NWT/BC, SK, MB, QC, NB, NS, PEI, YK, NWT
Strength: 
1%
Product Type: 
RX
Original: 
Dalacin® T

Category:

  • Antibiotique topique
  • Log in or register to post comments

Copyright © Taro Pharmaceutical Industries Ltd.  

Privacy Statement |  Terms of Use
Sitemap |  Site Credits